Recent Soleno-sponsored Posters and Presentations – Content provided on this page is intended for scientific exchange and may include references to, or data/information regarding a Soleno investigational product or use of a Soleno product that has not been FDA approved; no conclusions regarding the safety or efficacy can be made. Furthermore, this information should not be construed as recommendation for use of, or intent to promote a Soleno product for unapproved uses.
The content provided is intended for your personal and educational use only. Any further reproduction or distribution is not permitted without permission from the copyright owners or authors.
Poster
Pediatric Endocrine Society (PES 2025)
15-18 May 2025. National Harbor, MD.
Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal is Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in PWS (Study C614)
Obrynba K, Yanovski JA, Felner EI, et al.
Plain Language Summary (PLS)
Pediatric Endocrine Society (PES 2025)
15-18 May 2025. National Harbor, MD.
Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal is Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in PWS (Study C614)
Obrynba K, Yanovski JA, Felner EI, et al.
